<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38177896</PMID><DateCompleted><Year>2024</Year><Month>04</Month><Day>18</Day></DateCompleted><DateRevised><Year>2024</Year><Month>05</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1434-4726</ISSN><JournalIssue CitedMedium="Internet"><Volume>281</Volume><Issue>5</Issue><PubDate><Year>2024</Year><Month>May</Month></PubDate></JournalIssue><Title>European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery</Title><ISOAbbreviation>Eur Arch Otorhinolaryngol</ISOAbbreviation></Journal><ArticleTitle>Postinfectious conditions challenge disease-specificity of SNOT-22.</ArticleTitle><Pagination><StartPage>2395</StartPage><EndPage>2402</EndPage><MedlinePgn>2395-2402</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00405-023-08385-z</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">The Sino-Nasal-Outcome-Test 22 (SNOT-22) questionnaire assesses treatment outcome and health-related quality of life (HRQOL) in patients with chronic rhinosinusitis (CRS). However, given the overlap between CRS and olfaction in terms of nasal function and the definition of CRS, a fundamental question arises: can patients with olfactory dysfunction (OD) stemming from other causes attain SNOT-22 scores similar to those seen in CRS, even in the absence of CRS? Our study aimed to explore whether OD arising from various postinfectious mechanisms challenges the disease-specificity of SNOT-22 for CRS. If so, could focus on scores within specific symptom domains of SNOT-22 prove valuable in distinguishing between different etiologies.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The study adopted an observational, retrospective cohort design based on prospectively registered patients and related variables using the REDCap platform. 460 patients experiencing OD due to either (1) simple or (2) complex post-COVID-19, (3) postinfectious non-COVID-19, and (4) CRS, were included in the analysis.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The study revealed that the total SNOT-22 score lacks disease-specificity for CRS. This is evident, because complex postinfectious mechanisms resulting from COVID-19 can produce similar symptoms in patients. Notably, elevated total scores were primarily driven by high subdomain scores within the "sleep and cognition" domain.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The application of SNOT-22 as a screening tool needs to be approached with caution, as the total score alone does not provide disease-specific insights. A more thorough exploration of the four symptom domains and the identification of distinctive scoring patterns within the clinical context may prove pivotal in effectively differentiating between various underlying causes.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hildebrandt</LastName><ForeName>Mascha E</ForeName><Initials>ME</Initials><Identifier Source="ORCID">0000-0003-4905-8222</Identifier><AffiliationInfo><Affiliation>Department of Otorhinolaryngology, Head and Neck Surgery, G&#xf8;dstrup Hospital, University Clinic for Balance, Flavour and Sleep, Hospitalsparken 15, 7400, Herning, Denmark. mhilde@dadlnet.dk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>M&#xf8;ller</LastName><ForeName>Patrick R</ForeName><Initials>PR</Initials><Identifier Source="ORCID">0000-0001-6515-8755</Identifier><AffiliationInfo><Affiliation>Department of Otorhinolaryngology, Head and Neck Surgery, G&#xf8;dstrup Hospital, University Clinic for Balance, Flavour and Sleep, Hospitalsparken 15, 7400, Herning, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fj&#xe6;ldstad</LastName><ForeName>Alexander W</ForeName><Initials>AW</Initials><Identifier Source="ORCID">0000-0002-9135-6920</Identifier><AffiliationInfo><Affiliation>Department of Otorhinolaryngology, Head and Neck Surgery, G&#xf8;dstrup Hospital, University Clinic for Balance, Flavour and Sleep, Hospitalsparken 15, 7400, Herning, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Medicine, Aarhus University, Palle Juul-Jensen's Boulevard 82, 8200, Aarhus N, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ovesen</LastName><ForeName>Therese</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0003-0864-7987</Identifier><AffiliationInfo><Affiliation>Department of Otorhinolaryngology, Head and Neck Surgery, G&#xf8;dstrup Hospital, University Clinic for Balance, Flavour and Sleep, Hospitalsparken 15, 7400, Herning, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Medicine, Aarhus University, Palle Juul-Jensen's Boulevard 82, 8200, Aarhus N, Denmark.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>01</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Eur Arch Otorhinolaryngol</MedlineTA><NlmUniqueID>9002937</NlmUniqueID><ISSNLinking>0937-4477</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002908" MajorTopicYN="N">Chronic Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012220" MajorTopicYN="Y">Rhinitis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000079602" MajorTopicYN="N">Sino-Nasal Outcome Test</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012852" MajorTopicYN="Y">Sinusitis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Long COVID-19</Keyword><Keyword MajorTopicYN="N">Olfactory dysfunction</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">SNOT-22</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>10</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>11</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>4</Month><Day>18</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>1</Month><Day>5</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>1</Month><Day>4</Day><Hour>23</Hour><Minute>36</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38177896</ArticleId><ArticleId IdType="doi">10.1007/s00405-023-08385-z</ArticleId><ArticleId IdType="pii">10.1007/s00405-023-08385-z</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hopkins C, Gillett S, Slack R, Lund VJ, Browne JP (2009) Psychometric validity of the 22-item Sinonasal Outcome Test. Clin Otolaryngol 34(5):447&#x2013;454. https://doi.org/10.1111/j.1749-4486.2009.01995.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1749-4486.2009.01995.x</ArticleId><ArticleId IdType="pubmed">19793277</ArticleId></ArticleIdList></Reference><Reference><Citation>Stankevice D, Fjaeldstad AW, Agergaard J, Ovesen T (2023) Long-term COVID-19 smell and taste disorders differ significantly from other post-infectious cases. Laryngoscope 133(1):169&#x2013;174. https://doi.org/10.1002/lary.30453</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/lary.30453</ArticleId><ArticleId IdType="pubmed">36305529</ArticleId></ArticleIdList></Reference><Reference><Citation>Dejaco D et al (2019) The SNOT-22 factorial structure in European patients with chronic rhinosinusitis: new clinical insights. Eur Arch Otorhinolaryngol 276(5):1355&#x2013;1365. https://doi.org/10.1007/s00405-019-05320-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00405-019-05320-z</ArticleId><ArticleId IdType="pubmed">30739177</ArticleId><ArticleId IdType="pmc">6458972</ArticleId></ArticleIdList></Reference><Reference><Citation>Addison AB et al (2021) Clinical Olfactory Working Group consensus statement on the treatment of postinfectious olfactory dysfunction. J Allergy Clin Immunol 147(5):1704&#x2013;1719. https://doi.org/10.1016/j.jaci.2020.12.641</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2020.12.641</ArticleId><ArticleId IdType="pubmed">33453291</ArticleId></ArticleIdList></Reference><Reference><Citation>Damm M et al (2004) Riechst&#xf6;rungen. Epidemiologie und Therapie in Deutschland, &#xd6;sterreich und der Schweiz [Olfactory dysfunctions. Epidemiology and therapy in Germany, Austria and Switzerland]. HNO 52(2):112&#x2013;120. https://doi.org/10.1007/s00106-003-0877-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00106-003-0877-z</ArticleId><ArticleId IdType="pubmed">14968312</ArticleId></ArticleIdList></Reference><Reference><Citation>Fonteyn S, Huart C, Deggouj N, Collet S, Eloy P, Rombaux P (2014) Non-sinonasal-related olfactory dysfunction: a cohort of 496 patients. Eur Ann Otorhinolaryngol Head Neck Dis 131(2):87&#x2013;91. https://doi.org/10.1016/j.anorl.2013.03.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.anorl.2013.03.006</ArticleId><ArticleId IdType="pubmed">24679542</ArticleId></ArticleIdList></Reference><Reference><Citation>Fjaeldstad A, Stankovic J, Onat M, Stankevice D, Ovesen T (2020) Patients and experiences from the first danishflavour clinic. Dan Med J 67(4):1&#x2013;5</Citation><ArticleIdList><ArticleId IdType="pubmed">33576332</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S et al (2021) More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep. https://doi.org/10.1038/s41598-021-95565-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-95565-8</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId><ArticleId IdType="pmc">8352980</ArticleId></ArticleIdList></Reference><Reference><Citation>Boscolo-Rizzo P, Tofanelli M, Zanelli E, Gardenal N, Tirelli G (2023) COVID-19-related quantitative and qualitative olfactory and gustatory dysfunction: long-term prevalence and recovery rate. ORL J Otolaryngol Relat Spec 85(2):67&#x2013;71. https://doi.org/10.1159/000525861</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000525861</ArticleId></ArticleIdList></Reference><Reference><Citation>Alkodaymi MS et al (2022) Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: a systematic review and meta-analysis. Clin Microbiol Infect 28(5):657&#x2013;666. https://doi.org/10.1016/j.cmi.2022.01.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2022.01.014</ArticleId><ArticleId IdType="pubmed">35124265</ArticleId><ArticleId IdType="pmc">8812092</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan HQM, Pendolino AL, Andrews PJ, Choi D (2022) Prevalence of olfactory dysfunction and quality of life in hospitalised patients 1 year after SARS-CoV-2 infection: a cohort study. BMJ Open. https://doi.org/10.1136/bmjopen-2021-054598</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2021-054598</ArticleId><ArticleId IdType="pubmed">36691250</ArticleId><ArticleId IdType="pmc">9806069</ArticleId></ArticleIdList></Reference><Reference><Citation>Toma S, Hopkins C (2016) Stratification of SNOT-22 scores into mild, moderate or severe and relationship with other subjective instruments. Rhinology 54(2):129&#x2013;133. https://doi.org/10.4193/Rhino15.072</Citation><ArticleIdList><ArticleId IdType="doi">10.4193/Rhino15.072</ArticleId><ArticleId IdType="pubmed">27017484</ArticleId></ArticleIdList></Reference><Reference><Citation>Bech P, Timmerby N, Martiny K, Lunde M, Soendergaard S (2015) Psychometric evaluation of the Major Depression Inventory (MDI) as depression severity scale using the LEAD (Longitudinal Expert Assessment of All Data) as index of validity. BMC Psychiatry. https://doi.org/10.1186/s12888-015-0529-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12888-015-0529-3</ArticleId><ArticleId IdType="pubmed">26242577</ArticleId><ArticleId IdType="pmc">4526416</ArticleId></ArticleIdList></Reference><Reference><Citation>Danish Health Authority (2023) Danish Smoking Habits 2022</Citation></Reference><Reference><Citation>Danish Health Authority (2022) Danskernes sundhed: Den Nationale Sundhedsprofil 2021&#x2014;centrale udfordringer [Online]. www.sst.dk</Citation></Reference><Reference><Citation>Whitcroft KL, Altundag A, Balungwe P, Boscolo-Rizzo P (2023) Position paper on olfactory dysfunction: 2023. Rhinology. https://doi.org/10.4193/Rhin22.483</Citation><ArticleIdList><ArticleId IdType="doi">10.4193/Rhin22.483</ArticleId><ArticleId IdType="pubmed">37454287</ArticleId></ArticleIdList></Reference><Reference><Citation>Farhood Z, Schlosser RJ, Pearse ME, Storck KA, Nguyen SA, Soler ZM (2016) Twenty-two-item Sino-Nasal Outcome Test in a control population: a cross-sectional study and systematic review. Int Forum Allergy Rhinol 6(3):271&#x2013;277. https://doi.org/10.1002/alr.21668</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alr.21668</ArticleId><ArticleId IdType="pubmed">26610073</ArticleId></ArticleIdList></Reference><Reference><Citation>Nanayakkara JP, Igwe C, Roberts D, Hopkins C (2013) The impact of mental health on chronic rhinosinusitis symptom scores. Eur Arch Otorhinolaryngol 270(4):1361&#x2013;1364. https://doi.org/10.1007/s00405-012-2230-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00405-012-2230-1</ArticleId><ArticleId IdType="pubmed">23095946</ArticleId></ArticleIdList></Reference><Reference><Citation>Yim MT, Orlandi RR, Oakley GM, Alt JA (2021) The Sinonasal Outcome Test (SNOT-22) is a poor diagnostic tool for chronic rhinosinusitis. Ann Otol Rhinol Laryngol 130(11):1220&#x2013;1227. https://doi.org/10.1177/0003489421998213</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0003489421998213</ArticleId><ArticleId IdType="pubmed">33657861</ArticleId></ArticleIdList></Reference><Reference><Citation>Huerne K, Filion KB, Grad R, Ernst P, Gershon AS, Eisenberg MJ (2023) Epidemiological and clinical perspectives of long COVID syndrome. Am J Med Open. https://doi.org/10.1016/j.ajmo.2023.100033</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajmo.2023.100033</ArticleId><ArticleId IdType="pubmed">36685609</ArticleId><ArticleId IdType="pmc">9846887</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>